Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 9,220 shares of the stock in a transaction on Thursday, May 28th. The shares were bought at an average price of $4.17 per share, with a total value of $38,447.40. Following the purchase, the president directly owned 55,134 shares of the company’s stock, valued at $229,908.78. The trade was a 20.08% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora bought 6,420 shares of Auna stock. The stock was bought at an average cost of $4.15 per share, for a total transaction of $26,643.00.
- On Tuesday, May 26th, Leon Jesus Zamora purchased 30,000 shares of Auna stock. The shares were bought at an average price of $4.39 per share, with a total value of $131,700.00.
- On Wednesday, May 20th, Leon Jesus Zamora purchased 5,814 shares of Auna stock. The stock was bought at an average cost of $4.39 per share, with a total value of $25,523.46.
- On Wednesday, May 27th, Leon Jesus Zamora purchased 23,273 shares of Auna stock. The stock was bought at an average cost of $4.20 per share, with a total value of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora purchased 8,727 shares of Auna stock. The stock was purchased at an average price of $4.24 per share, for a total transaction of $37,002.48.
Auna Stock Down 0.6%
NYSE:AUNA opened at $4.52 on Wednesday. The firm has a market cap of $334.16 million, a P/E ratio of 17.37 and a beta of 0.81. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. Auna S.A. has a fifty-two week low of $4.09 and a fifty-two week high of $6.85. The firm has a 50-day simple moving average of $5.20 and a two-hundred day simple moving average of $5.01.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. Weiss Ratings restated a “sell (d)” rating on shares of Auna in a research note on Friday, March 27th. Finally, JPMorgan Chase & Co. lowered their price target on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Auna currently has a consensus rating of “Hold” and a consensus target price of $6.97.
Read Our Latest Analysis on AUNA
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. World Investment Advisors bought a new position in Auna during the fourth quarter valued at approximately $52,000. Clear Harbor Asset Management LLC purchased a new stake in Auna in the fourth quarter worth approximately $63,000. Sanctuary Advisors LLC bought a new stake in Auna in the 1st quarter worth approximately $71,000. Virtu Financial LLC purchased a new stake in Auna during the 3rd quarter valued at $75,000. Finally, Sage Investment Counsel LLC raised its stake in Auna by 60.0% during the 4th quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock valued at $79,000 after buying an additional 6,000 shares during the last quarter.
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Further Reading
- Five stocks we like better than Auna
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
